About this medicine

Diazepam has calming, muscle-relaxing and antiseizure effects. The treatment plan depends on the problem being treated; a short anxiety prescription is different from specialist epilepsy care.

The same active ingredient can be supplied for everyday oral treatment, a seizure-rescue plan or administration during a procedure. These are different clinical situations, with different instructions. A familiar generic name is not enough to identify the route, dose or monitoring required.

What is this medicine used for?

The checked tablets license severe adult anxiety for up to four weeks, anxiety-related insomnia, muscle spasm, selected epilepsy uses, premedication and acute alcohol withdrawal. They are not a routine long-term anxiety treatment.

Adjunctive epilepsy treatment means use alongside other care, not automatic replacement of a person’s regular antiseizure medicines. Rectal and injectable preparations have rapid-treatment roles; an oral anxiety schedule must never be used as instructions for seizure rescue. Alcohol withdrawal also needs assessment because seizures, confusion and other complications can make it dangerous.

Which warning signs need help?

Alcohol and opioids can turn sedation into life-threatening breathing suppression. Obtain emergency care for slow breathing, collapse or inability to wake: 999 in the UK, local emergency services elsewhere. Seek urgent advice after taking more than prescribed.

Physical dependence means adaptation that can produce withdrawal when treatment is reduced; addiction involves impaired control of use. They are not synonymous, and neither should be discussed with blame. MHRA strengthened communication in 2026 because dependence, addiction and tolerance can develop even during recommended treatment.

How do I take it safely?

The checked label gives adult anxiety doses of 5–30 mg daily in divided doses, adjusted individually. Older or debilitated patients often need less. Withdrawal treatment uses a supervised protocol; this article does not provide a home detoxification schedule.

UK preparations checked here also include Sandoz 2 mg/5 mL oral suspension, Diazepam Desitin 5 mg and 10 mg single-use rectal tubes, and hameln 5 mg/mL injection. They are separate products, not interchangeable instructions. Liquid is measured using the supplied or pharmacist-recommended device, not a kitchen spoon.

Rectal solution is given into the rectum under the prescribed rescue or treatment plan; Desitin is not recommended below 10 kg or one year. Injectable diazepam is administered by healthcare professionals, with route and monitoring chosen for the clinical setting. The injection’s ethanol and propylene glycol are important, particularly in children and with high cumulative exposure.

What side effects should I know about?

Drowsiness, tiredness, reduced alertness, dizziness and unsteadiness can occur. New agitation, worsening mood, memory problems or jaundice need medical review.

Low blood pressure can contribute to dizziness and falls. New jaundice, worsening depression or a substantial change in behaviour deserves prompt review. Do not drive, cycle or operate machinery while sleepy, confused or unsteady; reduced drowsiness after repeated use does not prove freedom from impairment.

Who needs extra care with this medicine?

Important exclusions include severe breathing or liver insufficiency, sleep apnoea, myasthenia gravis and acute porphyria. Diazepam is not appropriate as the only treatment for depression with anxiety.

The checked tablet contraindications also include phobic or obsessional states and chronic psychosis; older terminology elsewhere in its dose table must not be turned into a recommendation for OCD. Pregnancy planning and pregnancy carry explicit label restrictions. Clinicians also consider frailty, renal disease and substance-use history.

Can it affect my other medicines?

Sedating antihistamines, antipsychotics and some antidepressants can increase unwanted effects. Alcohol and grapefruit juice should be avoided. A pharmacist should check combinations before treatment changes.

Enzyme inhibitors such as fluvoxamine can prolong exposure, whereas an inducer such as carbamazepine can reduce it. Adding or stopping another medicine can therefore change a previously stable response. An opioid combination requires a specific clinical justification and close observation; separation by a few hours does not abolish additive breathing risk.

What check-ups will I need?

Review clinical benefit, alertness, falls, mood and signs of dependence. Alcohol-withdrawal treatment requires regular skilled monitoring of symptoms and sedation, not simply a supply of tablets.

Agree the purpose, expected duration and review plan at the outset. Follow-up considers symptom benefit, everyday functioning, memory, falls and any urge to escalate use, not only whether a person feels less anxious. Seizure rescue and procedural injection need their own observation and emergency plans.

What about pregnancy, breastfeeding and age?

Pregnancy and breastfeeding require professional advice because diazepam and its metabolites can reach the baby. Paediatric uses have their own indication and dose limits; adult anxiety schedules do not apply.

The Sovereign tablet SmPC advises against use in the first and third trimesters and against breastfeeding; NHS information allows an individually assessed short low-dose course during breastfeeding in some circumstances. These sources are not identical. Seek product-specific professional advice rather than abruptly stopping established treatment. Late-pregnancy exposure can affect newborn breathing, muscle tone, feeding or withdrawal.

Paediatric eligibility differs by product and indication. No adult tablet, rectal-tube or injection dose should be converted into a child’s regimen without the responsible clinician.

What if I miss a dose or want to stop?

Stopping regular treatment suddenly can cause withdrawal, including seizures. Agree a gradual reduction with the prescriber. NHS advice is to skip a missed dose and take the next normally, without doubling.

A reduction plan may take weeks or months and should respond to symptoms. MHRA advises gradual, flexible reductions with prescriber support; intolerable symptoms may require a pause or a revised plan. Short-term anxiety recommendations must not be used to stop necessary epilepsy treatment independently.

How does it work?

Diazepam strengthens the action of GABA, a chemical messenger that usually makes nerve cells less likely to become active. GABA works through receiving proteins called GABA-A receptors in the brain and spinal cord. These receptors help restrain electrical activity, a process called inhibition.

Diazepam attaches to the benzodiazepine site on the receptor, a separate place from where GABA attaches. This makes the receptor respond more strongly to the GABA signal. Because these connections help control several functions, the same broad action can produce relaxation, reduced seizure activity and unwanted sleepiness or impaired coordination.

How does it affect my body?

Sleepiness and reduced alertness can affect work, driving and balance. Older people are more susceptible to confusion and falls. Residual effects can persist after the immediate calming effect seems to have passed.

Memory for events after a dose can be affected, and coordination may be impaired without a person recognising the full effect. Unexpected agitation, aggression or hallucinations are possible paradoxical reactions, especially in children and older adults. Such a change needs assessment rather than simply increasing the dose.

How does my body process it?

Diazepam forms active metabolites, including nordiazepam, temazepam and oxazepam. Diazepam’s terminal half-life is around one to two days; nordiazepam can last longer. Repeated doses can therefore accumulate.

CYP3A4 and CYP2C19 help form the active metabolites. Age, liver disease and interacting medicines can alter exposure. The duration of feeling calm is therefore not a reliable guide to whether diazepam has cleared, and repeated doses may produce effects that become more evident over time.

How do treatment options differ?

NICE confines benzodiazepines for generalised anxiety to short crisis treatment. Diazepam lasts longer than lorazepam; dose conversions are approximate and require clinical judgement.

Long-lived active metabolites distinguish diazepam from benzodiazepines cleared mainly by simpler conjugation pathways. This can matter in older age or liver disease, but does not make one drug universally preferable. Switching or tapering needs a clinician’s judgement rather than a fixed online equivalence calculation.

A closer look at the science

It is a benzodiazepine receptor modulator. The same GABA-related actions contribute to anxiety relief, sedation, altered memory and muscle relaxation.

Diazepam belongs to the benzodiazepine family, but structural similarity does not create a reliable milligram-for-milligram substitution. Its active metabolites also contribute to effects after the parent medicine has begun to fall. A formulation changes how the medicine is delivered; it does not remove the molecule’s sedative or dependence risks.

How was this medicine developed?

Valium and the historical name Valrelease remain cross-edition aliases. This record verifies Sovereign oral tablets, rather than establishing availability of either named brand.

The long history of diazepam does not make older product instructions interchangeable with current UK ones. This expanded record now distinguishes oral tablets, suspension, rectal tubes and injection. US nasal and other rescue products are not presented as verified UK formulations.

Sources and References

  1. NHS: diazepam

    Scope: England (NHS patient information; not a uniform UK service pathway).

  2. Oral benzodiazepines and choosing equivalent doses — differences and licensed indications

    Scope: NHS Specialist Pharmacy Service (England); not a UK-wide commissioning or legal rule.

  3. Diazepam 2 mg tablets — SmPC, sections 4.1–4.9, 5.1–5.2 and 7–10

    Product information published on the electronic Medicines Compendium (emc); supplied by pharmaceutical companies.

    Scope: United Kingdom.

  4. Diazepam 2 mg, 5 mg and 10 mg tablets — patient leaflet, sections 1–4 and 6

    Product information published on the electronic Medicines Compendium (emc); supplied by pharmaceutical companies.

    Scope: United Kingdom product information.

  5. UK clinical guidelines for alcohol treatment — chapter 10, pharmacological interventions

    Scope: DHSC clinical guidance for UK alcohol treatment; local prescribing arrangements remain nation- and service-specific.

  6. Strengthened information on dependence, addiction, withdrawal and tolerance — benzodiazepines, Z-drugs and gabapentinoids

    Scope: United Kingdom.

  7. NICE CG113: generalised anxiety and panic disorder — drug-treatment recommendations on benzodiazepines

    Scope: NICE guidance (England-based); applicability and implementation in other UK nations require the relevant national pathway.

  8. Diazepam 2 mg/5 mL oral suspension — SmPC

    Product information published on the electronic Medicines Compendium (emc); supplied by pharmaceutical companies.

    Scope: United Kingdom.

  9. Diazepam Desitin 10 mg rectal solution — SmPC, including 5 mg presentation

    Product information published on the electronic Medicines Compendium (emc); supplied by pharmaceutical companies.

    Scope: United Kingdom.

  10. Diazepam Injection BP — SmPC

    Product information published on the electronic Medicines Compendium (emc); supplied by pharmaceutical companies.

    Scope: United Kingdom.

  11. Valium oral tablets: current October 2026 prescribing information — mechanism explanation

    Scope: Mechanism explanation only. Source sections checked: 12.1 Mechanism of Action; 12.2 Pharmacodynamics; 12.3 Pharmacokinetics. This does not establish UK product authorisation or prescribing..

  12. Diazepam: MedlinePlus Drug Information — mechanism explanation

    Scope: Mechanism explanation only. Source sections checked: Why is this medication prescribed?; What side effects can this medication cause?. This does not establish UK product authorisation or prescribing..

  13. NIMH: Understanding psychosis
  14. Schizophrenia

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top